For millions of people with age-related macular degeneration, the centre of their vision has gone dark.
AMD — specifically its advanced form, geographic atrophy — destroys the macula: the part of the retina responsible for sharp, central vision. Reading, recognising faces, watching a film, seeing a clock on the wall — all of it fades. Peripheral vision may remain, but the centre is gone. There is no approved treatment capable of restoring what is lost.
Until now, that may have meant a life without central vision.
A new study, published in March 2026 and drawing on results from a major international multi-centre clinical trial, has reported that a tiny wireless retinal implant called the PRIMA system has succeeded in doing what previous devices could not: giving central vision back.
The implant is 2 by 2 millimetres — smaller than a pencil eraser. It is placed under the damaged photoreceptor layer of the retina during a surgical procedure, where it replaces the destroyed light-sensing cells. The device converts light into electrical signals and transmits them directly to the remaining healthy retinal neurons, re-establishing the chain of communication between the eye and the brain.
Patients use the system in combination with specialised glasses that project images using infrared light.
In the trial, 26 out of 32 participants — 81% — achieved clinically meaningful improvements in visual acuity after one year of follow-up. On average, patients gained approximately 25 letters on a standard eye chart, equivalent to five full lines of improvement. Twenty-seven of the 32 participants reported using the artificial vision provided by the implant at home — reading numbers, words, and in some cases, whole pages of a book.
"Participants could read letters and words," researchers noted. "Some were able to read full pages."
This marks a fundamental departure from earlier retinal prosthetics, which primarily restored sensitivity to light rather than functional form vision. Previous devices could help patients detect movement or distinguish bright objects. The PRIMA system is restoring reading.
The team behind the research includes scientists at Stanford University's Department of Ophthalmology and the University of Pittsburgh Medical School, among others. The implant is being developed by Pixium Vision.
For people who have lost central vision to geographic atrophy — a condition affecting an estimated 5 million people in the US and Europe alone — this represents the most promising pathway to restoration yet trialled.
The dark centre of their vision may, one day soon, come back to light. 👁️